NASDAQ: MRNA - Invest Million

Moderna (NASDAQ: MRNA) Inks Agreement with Lonza

Moderna, Inc. (NASDAQ: MRNA) disclosed that it has inked an agreement with Lonza to back drug substance production for its global supply chain. The deal will build a new production line at Lonza’s Geleen site in the Netherlands.

Takeda Pharmaceutical Company Limited

Takeda (NYSE: TAK) Intends To Gain Approval For Moderna’s COVID19 Vaccine

Takeda Pharmaceutical Company Limited (NYSE: TAK) disclosed Friday that it has requested regulators to give authorization for the use of the COVID-19 vaccine of Moderna Inc (NASDAQ: MRNA).

Moderna Inc (MRNA)

Moderna (NASDAQ: MRNA) Teams Up With GC Pharma To Deliver COVID-19 Vaccine

Moderna Inc. (NASDAQ: MRNA) disclosed Thursday that it has teamed up with GC Pharma to deliver 40 million doses of COVID-19 vaccine to South Korea. GC Pharma has earlier entered

AstraZeneca PLC

AstraZeneca (NASDAQ: AZN) Dump 7.7% Stake In Moderna Inc (NASDAQ: MRNA)

AstraZeneca Plc (NASDAQ: AZN) disclosed that it has dumped 7.7% stakes in US biotechnology firm Moderna Inc. AZN has dumped the holdings of Moderna Inc (NASDAQ: MRNA) for more than $1 billion.

$MRNA

Moderna (NASDAQ: MRNA) Inks 160M COVID Vaccine Doses Supply Deal With EU

Moderna, Inc. (NASDAQ: MRNA) has secured a supply contract for up to 160 million doses of COVID-19 vaccine candidates from the European Union. Moderna Inc. has earlier disclosed that its experimental COVID-19 vaccine has shown 94.5% effectiveness in limiting this novel disease. EU

Investments

Moderna Inc (NASDAQ: MRNA) Rallies As It Continues To Work On Coronavirus Vaccine

Moderna Inc (NASDAQ: MRNA) like a host of other biotech stocks was in the green in yesterday’s session. This was driven by investor speculation on companies that are looking into Coronavirus. In yesterday’s session, MRNA rallied to close the day with gains